Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Chemomab Therapeutics Q3 EPS $(0.04) Beats $(0.33) Estimate

Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.33) by 89.39 percent. This is a 86.54 percent increase over losses of $(0.26) per share
byBenzinga Newsdesk
November 11, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.33) by 89.39 percent. This is a 86.54 percent increase over losses of $(0.26) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Canadian Politician Blasts Grocery Store’s $1 Million In Daily ‘EXCESS Profits’. Here’s How Much The Company Actually Makes – Plus Two U.S. Counterparts That Are Returning Profits To Investors

By Jing Pan
April 14, 12:02 PM
Whether it was uncertainties brought by the COVID-19 pandemic or challenges from rising interest rates, the grocery store industry has proven to be remarkably resilient. But Canada’s New Democratic Party leader Jagmeet Singh is not a fan.

KR